CASEY GAYER: Open Payments
NPI 1922288596 · MASSILLON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,729 in 131 payments from 26 companies in 2025. Trend: 2023 $2,702 · 2024 $2,138 · 2025 $2,729
Food & beverage: $2,729
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $442 |
| Novartis Pharmaceuticals Corporation | 10 | $225 |
| Axsome Therapeutics, Inc. | 9 | $224 |
| Teva Pharmaceuticals USA, Inc. | 22 | $213 |
| Lilly USA, LLC | 5 | $191 |
| Neurocrine BioSciences, Inc. | 5 | $182 |
| EMD Serono, Inc. | 13 | $168 |
| Genentech USA, Inc. | 6 | $151 |
| UCB, Inc. | 4 | $150 |
| PFIZER INC. | 6 | $116 |
Products named: QULIPTA, KESIMPTA, Symbravo, AUSTEDO XR, INGREZZA, UBRELVY, Ocrevus Zunovo, KISUNLA.
Industry payments across OH — which companies pay providers there.
